期刊文献+

对比分析加巴喷丁与盐酸度洛西汀对糖尿病周围神经痛的临床疗效 被引量:7

Comparative analysis of clinical efficacy of gabapentin and duloxetine on diabetic peripheral neuropathic pain
原文传递
导出
摘要 目的对比分析加巴喷丁与盐酸度洛西汀对糖尿病周围神经痛的临床治疗效果与不良反应。方法将菏泽医学专科学校附属医院2010年2月至2011年8月收治的65例2型糖尿病伴糖尿病周围神经痛患者随机分成两组,观察组给予盐酸度洛西汀治疗,对照组给予加巴喷丁治疗,采用视觉模拟评分法(VAS)对疼痛情况做出评估。结果与给药前的VAS比较,观察组与对照组患者给药后第7、14、28天时的VAS均出现明显降低(P〈0.01),两组患者同期的VAS分值比较差异无统计学意义(P〉0.05),给药后两组同期有效率相比差异无统计学意义(P〉0.05)。观察组不良反应明显低于对照组,差异有统计学意义(P〈0.01)。结论采用加巴喷丁与盐酸度洛西汀治疗糖尿病周围神经痛均具有理想的治疗效果,但盐酸度洛西汀的不良反应发生率显著低于加巴喷丁,患者的依从性较好,值得临床推广应用。 Objective To compare the clinical effect and side effects of gabapentin and duloxetine on diabetic peripheral neuropathic pain(DPNP). Methods Sixty-five patients with type 2 diabetes combined with DPNP admitted to the affiliated hospital of Heze medical college from February 2010 to August 2011 were randomly divided into two groups, the observation group were treated with duloxetine, and the control group received gabapentin, the pain were evaluated by visual analog scale (VAS). Resuits Compared with the VAS before treatment, the VAS scores after treatment on the 7 th, 14 th and 28 th day of the two groups were significantly lower ( P 〈 0. 01 ), there was no significant difference of the VAS scores between the two groups over the same period (P 〉 0.05 ), and there was no significant difference between the two groups after administration of the same period in efficiency (P 〉 0.05 ). The side effects of the observation group were significantly lower than that of the control group (P 〈 0. 01 ). Conclusions Gabapentin and duloxetine treatment of diabetic peripheral neuropathic pain had the desired therapeutic effect, but the side effects of duloxetine were significantly lower than that of gabapentin, and the patients'compliance is good and worthy of clinical application.
作者 王中英
出处 《中国实用医刊》 2013年第8期10-11,共2页 Chinese Journal of Practical Medicine
关键词 糖尿病周围神经痛 加巴喷丁 盐酸度洛西汀 临床疗效 Diabetic peripheral neuropathic pain Gabapentin Duloxetine hydrochloride Clinical efficacy
  • 相关文献

参考文献6

二级参考文献8

  • 1蒋丙年.实用神经病学.第2版.上海:上海科学技术出版社,1999:980.
  • 2Wang J, Liu X, Mullins CD. Treatment adherence and persistence with du- loxetine, venlafaxine XR,and escitalopram among patients with major de- pressive disorder and chronic pain-related diseases [J]. Curr Med ResOpin,2011 ;27(7) :1303-13.
  • 3Raskin J,Smith TR,Wong K, et al. Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain [J].J Palli- at Med,2006 ;9( 1 ) :29-40.
  • 4Wernieke JF, Raskin J, Rosen A, et al. Duloxetine in the long-term man- agement of diabetic peripheral neuropathie pain : an open-label, 52-week extension of a randomized controlled elinieal trial[J].Curr Therap Res,2006;65(5) : 283-304.
  • 5Wernicke JF,Wang F,Pritchett YL,et al. An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabeticperipheral neuropathic pain [J].Pain Med, 2007 ; 8 ( 6 ) : 503-13.
  • 6李全波,郑宝森.糖尿病周围神经痛研究与治疗进展——2008年第12届世界疼痛大会综述之五[J].实用疼痛学杂志,2009,5(1):69-72. 被引量:8
  • 7翁建平.对糖尿病流行病学、循证医学及基础研究的探索[J].中山大学学报(医学科学版),2010,31(2):166-171. 被引量:147
  • 8励丽,褚建平,李佳霖.度洛西汀治疗痛性糖尿病神经病变的临床观察[J].中国临床药学杂志,2011,20(2):89-91. 被引量:9

共引文献8

同被引文献60

  • 1老年病科,王涤非,邱忠霞,蒋丽娟,张锦.抗抑郁治疗对糖尿病痛性神经病变伴抑郁焦虑的影响[J].山西医药杂志,2006,35(4):297-299. 被引量:12
  • 2王尚君.卡马西平、丙戊酸钠治疗三叉神经痛疗效比较[J].中国医药导报,2007,4(01Z):98-99. 被引量:9
  • 3杨李,邹瑞,唐瑛,王小昆.链脲佐菌素和高脂高糖饲料在大鼠体内的相互作用及造模应用[J].实用医学杂志,2007,23(18):2845-2846. 被引量:10
  • 4Wang H, Romano G, Frustaei ME, et al. Fulranumah for treatment of di- abetic peripheral neuropathic pain : A randomized controlled trial [ J ]. Neurology ,2014,83 (7) :628-637.
  • 5ArgoffCE, ColeBE, FishbainDA,et al. Diabetic peripheral neuropathic pain:clinical and quality-of-life issues[J]. Mayo Clin Proc,2006,81(4 Suppl):S3-S11.
  • 6DanaeiG, FinucaneMM, LuY,et al. National,regional,and global trends in fasting plasma glucose and diabetes prevalence since 1980:systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants[J]. Lancet,2011,378(9785):31-40.
  • 7AbbottCA, MalikRA, Van RossER,et al. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K.[J]. Diabetes Care,2011,34(10):2220-2224.
  • 8GoldsteinDJ, LuY, DetkeMJ,et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy[J]. Pain,2005,116(1-2):109-118.
  • 9WuFX, BianJJ, MiaoXR,et al. Intrathecal siRNA against Toll-like receptor 4 reduces nociception in a rat model of neuropathic pain[J]. Int J Med Sci,2010,7(5):251-259.
  • 10O'NeillLA. Signal transduction pathways activated by the IL-1 receptor/toll-like receptor superfamily[J]. Curr Top Microbiol Immunol,2002,270(3):47-61.

引证文献7

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部